The failure of glycopeptide antibiotics led to the creation of a new class of drug, the streptogramins, a combination of quini pristin and dalfopristin. Quinupristin/ dalfopristin (Synercid AE ...
To understand how the ancestor of today's glycopeptide antibiotics—such as vancomycin, ristomycin and teicoplanin—might have looked like, the researchers used a combination of bioinformatics ...
The antibiotics market generated sales of US ... Theravance/Astellas), a glycopeptide approved in 2009; retapamulin (Altabax; GlaxoSmithKline), a pleuromutilin approved in 2008; and tigecycline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback